Detailed information for compound 410786

Basic information

Technical information
  • TDR Targets ID: 410786
  • Name: 7-(2-aminophenyl)-5-[3-[4-(3-chlorophenyl)pip erazin-1-yl]propyl]-3-methyl-[1,2]oxazolo[4,5 -d]pyridazin-4-one
  • MW: 478.974 | Formula: C25H27ClN6O2
  • H donors: 1 H acceptors: 2 LogP: 3.97 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1cccc(c1)N1CCN(CC1)CCCn1nc(c2ccccc2N)c2c(c1=O)c(C)no2
  • InChi: 1S/C25H27ClN6O2/c1-17-22-24(34-29-17)23(20-8-2-3-9-21(20)27)28-32(25(22)33)11-5-10-30-12-14-31(15-13-30)19-7-4-6-18(26)16-19/h2-4,6-9,16H,5,10-15,27H2,1H3
  • InChiKey: QAEWDZPFGWXERV-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 7-(2-aminophenyl)-5-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-3-methyl-isoxazolo[4,5-d]pyridazin-4-one
  • 7-(2-aminophenyl)-5-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3-methyl-4-isoxazolo[4,5-d]pyridazinone
  • 7-(2-aminophenyl)-5-[3-[4-(3-chlorophenyl)piperazino]propyl]-3-methyl-isoxazolo[4,5-d]pyridazin-4-one

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0022 0.1961 0.128
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0015 0.0781 0.0781
Entamoeba histolytica hypothetical protein 0.0038 0.4628 0.4172
Entamoeba histolytica hypothetical protein 0.0038 0.4628 0.4172
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Mycobacterium ulcerans DNA polymerase IV 0.0043 0.5538 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0038 0.4628 0.4628
Onchocerca volvulus Protein ultraspiracle homolog 0.0011 0 0.5
Onchocerca volvulus Steroid hormone receptor family member cnr14 homolog 0.0011 0 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0022 0.1961 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0017 0.1158 0.0408
Loa Loa (eye worm) ImpB/MucB/SamB family protein 0.0015 0.0781 0.0781
Echinococcus granulosus dna polymerase eta 0.0015 0.0781 0.0781
Loa Loa (eye worm) tyrosyl-DNA phosphodiesterase 0.0069 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0017 0.1158 0.0408
Echinococcus multilocularis tyrosyl DNA phosphodiesterase 1 0.0069 1 1
Trypanosoma brucei DNA polymerase IV, putative 0.0043 0.5538 0.516
Trypanosoma brucei DNA polymerase kappa, putative 0.0017 0.1158 0.0408
Entamoeba histolytica hypothetical protein 0.0038 0.4628 0.4172
Toxoplasma gondii BRCA1 C Terminus (BRCT) domain-containing protein 0.0012 0.0176 0.5
Entamoeba histolytica tyrosyl-DNA phosphodiesterase, putative 0.0069 1 1
Onchocerca volvulus Bile acid receptor homolog 0.0011 0 0.5
Schistosoma mansoni transcription factor LCR-F1 0.0038 0.4628 0.4628
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0015 0.0781 0.0781
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0043 0.5538 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Brugia malayi ImpB/MucB/SamB family protein 0.0015 0.0781 0.0781
Echinococcus granulosus transcription factor Dp 1 0.004 0.5027 0.5027
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Trypanosoma brucei DNA polymerase kappa, putative 0.0022 0.1961 0.128
Brugia malayi hypothetical protein 0.0038 0.4628 0.4628
Echinococcus granulosus tyrosyl DNA phosphodiesterase 1 0.0069 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0032 0.3752 0.3223
Trypanosoma cruzi DNA polymerase kappa, putative 0.0043 0.5538 0.516
Brugia malayi polk-prov protein 0.0032 0.3752 0.3752
Trypanosoma cruzi DNA polymerase kappa, putative 0.0043 0.5538 0.516
Trichomonas vaginalis DNA polymerase eta, putative 0.0043 0.5538 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Leishmania major tyrosyl-DNA phosphodiesterase 1 0.0069 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Leishmania major DNA polymerase kappa, putative 0.0022 0.1961 0.128
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0015 0.0781 0.0781
Schistosoma mansoni DNA polymerase eta 0.0015 0.0781 0.0781
Schistosoma mansoni terminal deoxycytidyl transferase 0.0015 0.0781 0.0781
Trypanosoma brucei unspecified product 0.0036 0.4358 0.3879
Loa Loa (eye worm) hypothetical protein 0.0015 0.0781 0.0781
Trypanosoma cruzi tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0069 1 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0043 0.5538 0.516
Echinococcus granulosus dna polymerase kappa 0.0043 0.5538 0.5538
Schistosoma mansoni hypothetical protein 0.0054 0.7443 0.7443
Echinococcus multilocularis dna polymerase eta 0.0015 0.0781 0.0781
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Trypanosoma brucei DNA polymerase IV, putative 0.0043 0.5538 0.516
Onchocerca volvulus 0.0011 0 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0043 0.5538 0.516
Trypanosoma brucei tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0069 1 1
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0038 0.4628 0.4628
Trypanosoma brucei DNA polymerase IV, putative 0.0036 0.4358 0.3879
Echinococcus multilocularis dna polymerase kappa 0.0043 0.5538 0.5538
Giardia lamblia DINP protein human, muc B family 0.0022 0.1961 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0032 0.3752 0.3223
Loa Loa (eye worm) hypothetical protein 0.0032 0.3752 0.3752
Entamoeba histolytica hypothetical protein 0.0038 0.4628 0.4172
Trypanosoma cruzi tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0069 1 1
Mycobacterium ulcerans DNA polymerase IV 0.0043 0.5538 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.0043 0.5538 0.516
Echinococcus multilocularis transcription factor Dp 1 0.004 0.5027 0.5027
Schistosoma mansoni tyrosyl-DNA phosphodiesterase 0.0069 1 1
Schistosoma mansoni hypothetical protein 0.0038 0.4628 0.4628
Brugia malayi ImpB/MucB/SamB family protein 0.0015 0.0781 0.0781

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 16.5 Antinociceptive activity in Swiss Albino mouse at 20 mg/kg, po by hot plate assay measured as licking latency ChEMBL. 17181165
Activity (functional) = 28 Antinociceptive activity in Swiss Albino mouse at 20 mg/kg, po by writhing test measured as number of writhes ChEMBL. 17181165
Activity (functional) = 16.5 Antinociceptive activity in Swiss Albino mouse at 20 mg/kg, po by hot plate assay measured as licking latency ChEMBL. 17181165
Activity (functional) = 28 Antinociceptive activity in Swiss Albino mouse at 20 mg/kg, po by writhing test measured as number of writhes ChEMBL. 17181165

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.